Remove Chemotherapy Remove Drug Development Remove Research Laboratories
article thumbnail

MSD set to acquire novel antibody for B-cell malignancies

European Pharmaceutical Review

Progress in immunotherapy drug development In June, the US Food and Drug Administration (FDA) authorised an immunotherapy combination to treat endometrial cancer. The bispecific antibody has shown potential to generate “significant and sustained reductions in B-cell populations”.